Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet-Reference-Cited by-同舟云学术

Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet

Published:2021-12-11 Issue: Volume: Page:
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Velden Vincent H. J.¹^ORCID,Preijers Frank²,Johansson Ulrika³^ORCID,Westers Theresia M.⁴,Dunlop Alan⁵,Porwit Anna⁶^ORCID,Béné Marie C.⁷^ORCID,Valent Peter⁸⁹,Marvelde Jeroen¹,Wagner‐Ballon Orianne¹⁰^ORCID,Oelschlaegel Uta¹¹,Saft Leonie¹²,Kordasti Sharham¹³,Ireland Robin¹³,Cremers Eline¹⁴,Alhan Canan⁴,Duetz Carolien⁴,Hobo Willemijn²,Chapuis Nicolas¹⁵^ORCID,Fontenay Michaela¹⁵,Bettelheim Peter¹⁶,Eidenshink‐Brodersen Lisa¹⁷,Font Patricia¹⁸,Loken Michael R.¹⁷,Matarraz Sergio¹⁹²⁰,Ogata Kiyoyuki²¹,Orfao Alberto¹⁹²⁰,Psarra Katherina²²,Subirá Dolores²³^ORCID,Wells Denise A.¹⁷,Della Porta Matteo G.²⁴,Burbury Kate²⁵,Bellos Frauke²⁶,Weiß Elisabeth²⁶,Kern Wolfgang²⁶,Loosdrecht Arjan⁴

Affiliation:

1. Laboratory Medical Immunology, Department of Immunology Erasmus MC, University Medical Center Rotterdam Rotterdam The Netherlands

2. Department of Laboratory Medicine – Laboratory for Hematology Radboudumc, Nijmegen The Netherlands

3. Laboratory Medicine SI‐HMDS, University Hospitals Bristol and Weston NHS Foundation Trust Bristol UK

4. Department of Hematology Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam Amsterdam The Netherlands

5. Department of Haemato‐Oncology Royal Marsden Hospital Sutton Surrey UK

6. Department of Clinical Sciences, Division of Oncology And Pathology, Faculty of Medicine Lund University Lund Sweden

7. Hematology Biology Nantes University Hospital and CRCINA Nantes France

8. Department of Internal Medicine I, Division of Hematology & Hemostaseology Medical University of Vienna Vienna Austria

9. Ludwig Boltzmann Institute for Hematology and Oncology Medical University of Vienna Vienna Austria

10. Department of Hematology and Immunology; and Université Paris‐Est Créteil Assistance Publique‐Hôpitaux de Paris, University Hospital Henri Mondor Inserm U955, Créteil France

11. Department of Internal Medicine University Hospital Carl‐Gustav‐Carus Dresden TU Germany

12. Department of Clinical Pathology and Oncology Karolinska University Hospital and Institute Solna Stockholm Sweden

13. Comprehensive Cancer Centre King's College London and Hematology Department, Guy's Hospital London UK

14. Department of Internal Medicine, Division of Hematology Maastricht University Medical Center AZ, Maastricht The Netherlands

15. Assistance Publique‐Hôpitaux de Paris. Centre‐Université de Paris Cochin Hospital, Laboratory of Hematology and Université de Paris, Institut Cochin, INSERM U1016, CNRS UMR8104 Paris France

16. Department of Internal Medicine Ordensklinikum Linz Barmherzige Schwestern – Elisabethinen Linz Austria

17. Hematologics Inc Seattle WA USA

18. Department of Hematology Hospital General Universitario Gregorio Marañon‐IiSGM Madrid Spain

19. Cancer Research Center (IBMCC, USAL‐CSIC), Department of Medicine and Cytometry Service University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL) Salamanca Spain

20. Biomedical Research Networking Centre Consortium of Oncology (CIBERONC) Instituto Carlos III Salamanca Spain

21. Metropolitan Research and Treatment Centre for Blood Disorders (MRTC Japan) Tokyo Japan

22. Immunology Histocompatibility Department Evangelismos Hospital Athens Greece

23. Flow Cytometry Unit. Department of Hematology Hospital Universitario de Guadalajara Guadalajara Spain

24. IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy & Department of Biomedical Sciences Humanitas University, Pieve Emanuele Milan Italy

25. Department of Haematology Peter MacCallum Cancer Centre, University of Melbourne Melbourne Australia

26. MLL Munich Leukemia Laboratory Munich Germany

Funder

Austrian Science Fund

Horizon 2020 Framework Programme

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.b.22046

Reference62 articles.

1. Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood

2. Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood

3. A pilot study on the usefulness of peripheral blood flow cytometry for the diagnosis of lower risk myelodysplastic syndromes: the “MDS thermometer”

4. CD177 Enhances the Detection of Myelodysplastic Syndrome by Flow Cytometry

5. A novel method to assess bone marrow purity is useful in determining blast percentage by flow Cytometry in acute myeloid leukemia and Myelodysplasia;Aldawood A. M.;Annals of Hematology & Oncology,2015

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometry in acute myeloid leukemia and detection of minimal residual disease;Clinica Chimica Acta;2025-01

2. Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium;HemaSphere;2024-05

3. Technical, gating and interpretation recommendations for the partitioning of circulating monocyte subsets assessed by flow cytometry;Cytometry Part B: Clinical Cytometry;2024-04-24

4. Measurable (Minimal) Residual Disease in Myelodysplastic Neoplasms (MDS): Current State and Perspectives;Cancers;2024-04-15

5. Normal and malignant cells are homogeneously distributed in the bone marrow of children;Leukemia & Lymphoma;2024-04-08